Abstract
An increased lipopolysaccharide (LPS) level in patients with cirrhosis induced the dysregulation of sterol regulatory element–binding transcription factor 2 (SREBF2), which participated in the modulation of tumor inflammatory microenvironment. However, the role of SREBF2 in the LPS-induced injury of portal vein endothelium was scarcely reported. This study aimed to investigate the effects of SREBF2 on the LPS-induced injury to endothelial cells (ECs) in vitro and in vivo and explore the underlying mechanism. In this study, we found that LPS increased SREBF2 expression through activating the TLR4/JNK/c-Jun pathway and suppressed UBE2I-mediated SREBF2 sumoylation to enhance its transcriptional activity. The dysregulation of SREBF2 induced ER stress by increasing the intracellular cholesterol level and facilitated Bax expression to cause additional damage to LPS-induced ECs. As a potential intervention, miR590-3p negatively regulated SREBF2 expression and upregulated UBE2I expression by targeting TLR4, thus alleviating LPS-induced injury. These results suggest that LPS-induced SREBF2 triggered ER stress and promoted Bax expression to injure ECs, which was reversed by miR590-3p. The mechanisms of SREBF2 mediated LPS-induced endothelial injury of portal vein, which might be the therapeutic target for PVT development in cirrhosis patients.
Graphical abstract
Similar content being viewed by others
Data Availability
Not applicable.
Code availability
Not applicable.
References
Ancel D, Barraud H, Peyrinbiroulet L, Bronowicki JP. Intestinal permeability and cirrhosis. Gastroenterol Clin Biol. 2006;30(3):460–8.
Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5(1):22–40.
Chen X, Zhang C, Zhao M, Shi CE, Zhu RM, Wang H, et al. Melatonin alleviates lipopolysaccharide-induced hepatic SREBP-1c activation and lipid accumulation in mice. J Pineal Res. 2011;51(4):416–25.
Chen Y, Wu Z, Yuan B, Dong Y, Zhang L, Zeng Z. MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway. Cell Death Dis. 2018;9(2):22.
Dembek A, Laggai S, Kessler SM, Czepukojc B, Simon Y, Kiemer AK, et al. Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation. Immunobiology. 2017;222(6):786–96.
Deng X, Pan X, Cheng C, Liu B, Zhang H, Zhang Y, et al. Regulation of SREBP-2 intracellular trafficking improves impaired autophagic flux and alleviates endoplasmic reticulum stress in NAFLD. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(3):337–50.
Du Plessis J, Vanheel H, Janssen CE, Roos L, Slavik T, Stivaktas PI, et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol. 2013;58(6):1125–32.
Funk JL, Feingold KR, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. ATHEROSCLEROSIS. 1993;98(1):67–82.
Gibot L, Follet J, Metges JP, Auvray P, Simon B, Corcos L, et al. Human caspase 7 is positively controlled by SREBP-1 and SREBP-2. Biochem J. 2009;420(3):473–83.
Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49(5):842–856.e7.
He M, Zhang W, Dong Y, Wang L, Fang T, Tang W, et al. Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells. J Exp Clin Cancer Res. 2017;36(1):15.
Huang J, Peng W, Zheng Y, Hao H, Li S, Yao Y, et al. Upregulation of UCP2 expression protects against LPS-induced oxidative stress and apoptosis in cardiomyocytes. Oxidative Med Cell Longev. 2019;2019:2758262.
Lhoták S, Sood S, Brimble E, Carlisle RE, Colgan SM, Mazzetti A, et al. ER stress contributes to renal proximal tubule injury by increasing SREBP-2-mediated lipid accumulation and apoptotic cell death. Am J Physiol Ren Physiol. 2012;303(2):F266–78.
Li C, Pan J, Ye L, Xu H, Wang B, Xu H, et al. Autophagy regulates the therapeutic potential of adipose-derived stem cells in LPS-induced pulmonary microvascular barrier damage. Cell Death Dis. 2019;10(11):804.
Li LC, Varghese Z, Moorhead JF, Lee CT, Chen JB, Ruan XZ. Cross-talk between TLR4-MyD88-NF-kB and SCAP-SREBP2 pathways mediates macrophage foam cell formation. Am J Physiol Heart Circ Physiol. 2013;304(6):H874–84.
Liu B, Zhao H, Wang Y, Zhang H, Ma Y. Astragaloside IV attenuates lipopolysaccharides-induced pulmonary epithelial cell injury through inhibiting autophagy. Pharmacology. 2020;105(1-2):90–101.
Liu H, Wang J, Chen Y, Chen Y, Ma X, Bihl JC, et al. NPC-EXs alleviate endothelial oxidative stress and dysfunction through the miR-210 downstream Nox2 and VEGFR2 pathways. Oxidative Med Cell Longev. 2017;2017:9397631.
Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology. 2017;153(2):480–487.e1.
Logette E, Le Jossic-Corcos C, Masson D, Solier S, Sequeira-Legrand A, Dugail I, et al. Caspase-2, a novel lipid sensor under the control of sterol regulatory element binding protein 2. Mol Cell Biol. 2005;25(21):9621–31.
Ma J, Li YT, Zhang SX, Fu SZ, Ye XZ. MiR-590-3p attenuates acute kidney injury by inhibiting tumor necrosis factor receptor-associated factor 6 in septic mice. Inflammation. 2019;42(2):637–49.
Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, et al. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovasc Res. 2013;100(3):450–60.
Ma X, Bi E, Huang C, Lu Y, Xue G, Guo X, et al. Cholesterol negatively regulates IL-9-producing CD8(+) T cell differentiation and antitumor activity. J Exp Med. 2018a;215(6):1555–69.
Ma Y, Liu Y, Hou H, Yao Y, Meng H. MiR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2018b;500(3):828–37.
Manigold TB, Cker U, Hanck C, Gundt J, Traber P, Antoni C, et al. Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2003;15(3):275–82.
Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res. 2013;52(1):175–91.
Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem. 2001;276(24):21664–9.
Shah D, Das P, Alam MA, Mahajan N, Romero F, Shahid M, et al. MicroRNA-34a promotes endothelial dysfunction and mitochondrial-mediated apoptosis in murine models of acute lung injury. Am J Respir Cell Mol Biol. 2019;60(4):465–77.
Tahmasebi S, Ghorbani M, Savage P, Gocevski G, Yang XJ. The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency. Stem Cells. 2014;32(4):1012–20.
Victorov AV, Gladkaya EM, Novikov DK, Kosykh VA, Yurkiv VA. Lipopolysaccharide toxin can directly stimulate the intracellular accumulation of lipids and their secretion into medium in the primary culture of rabbit hepatocytes. FEBS Lett. 1989;256(1-2):155–8.
Violi F, Lip GY, Cangemi R. Endotoxemia as a trigger of thrombosis in cirrhosis. Haematologica. 2016;101(4):e162–3.
Wang Y, Mao X, Chen H, Feng J, Yan M, Wang Y, et al. Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in macrophages by eliminating damaged mitochondria via PINK1 mediated mitophagy. Int Immunopharmacol. 2019;73:471–81.
Wiese CB, Zhong J, Xu ZQ, Zhang Y, Ramirez SM, Zhu W, et al. Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis. Atherosclerosis. 2019;282:121–31.
Yoshino T, Tabunoki H, Sugiyama S, Ishii K, Kim SU, Satoh J. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2. Cell Mol Neurobiol. 2011;31(7):1009–20.
Zhang J, Guo Y, Ge W, Zhou X, Pan M. High glucose induces the apoptosis of HUVECs in mitochondria dependent manner by enhancing VDAC1 expression. Pharmazie. 2018;73(12):725–8.
Zong Y, Wu P, Nai C, Luo Y, Hu F, Gao W, et al. Effect of microRNA-30e on the behavior of vascular smooth muscle cells via targeting ubiquitin-conjugating enzyme E2I. Circ J. 2017;81(4):567–76.
Funding
This work was supported by the Shanghai Sailing Program (No. 19YF1406500) and partly supported by the National Natural Science Foundation of China (No. 81900511) and Innovation Fund of Science and Technology Commission of Shanghai Municipality (No. 19411970200).
Author information
Authors and Affiliations
Contributions
G.D., X.-Q.H., and S.-Y.C. developed and designed the study concept. G.D. and X.-Q.H. analyzed in vitro experimental data and drafted this article. L.W., S.-Y.J., and Q.-T.T. performed animal experiments and analyzed the data. S.-Y.C. supervised the research and provided critical review and revised version of this manuscript.
Corresponding author
Ethics declarations
Ethics approval
The ethics committee of Zhongshan Hospital of Fudan University (Shanghai, China) approved all animal experiments.
Consent to participate
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Figure S1
SREBF2 interacts with UBE2I or SUMO-1. (A-B) Co-IP assays were used to verify these interactions before and after LPS treatment. (C) Dual-luciferase reporter assays performed in LPS-treated ECs transfected with WT plasmid containing SREBF2-binding sites in the HMGCR promoter using Lipofectamine 2000 after the overexpression of Sumo-1. *P < 0.05, **P < 0.01. (TIF 816 kb)
Figure S2
Effects of LPS on SCAP intracellular translocation. (A) Confocal microscopy was used to detect SCAP intracellular translocation by staining with the antibody SCAP (red) and GM-130 antibody (Golgi, green). (TIF 19030 kb)
Figure S3
Effects of LPS on SREBF1expression. (A) SREBF1 expression determined by RT-PCR or (B-C) Western blot. *P < 0.05. (TIF 749 kb)
Figure S4
The activation of SREBF2 pathway in cells cultured with FCS-free medium treated by LPS. (A-B) SREBF2, HMGCR and LDLR expression determined by Western blot. *P < 0.05, **P < 0.01. (TIF 19248 kb)
Figure S5
mRNA and protein levels of SREBF2 target genes such as LDLR and HMGCR after c-Jun overexpression. (A-B) Protein levels of LDLR and HMGCR after c-Jun overexpression were detected by Western blot. (C) mRNA levels of LDLR and HMGCR after c-Jun overexpression were detected by qRT-RCR. *P < 0.05, **P < 0.01. (TIF 18999 kb)
Figure S6
mRNA levels of UBE2I after LPS treatment detected by qRT-RCR. *P < 0.05. (TIFF 128 kb)
Figure S7
TLR4 and miR590-3p expression in control and LPS-treated cells. RT-qPCR analysis of TLR4 and miR590-3p in control and LPS-treated cells. *P < 0.05, **P < 0.01. (TIF 19049 kb)
Figure S8
Quantitative analysis of western blot bands from Figure 1, 2, 3, 4, 5, 6, 7 and 8. (A) Quantitative analysis of western blot bands Figure 1. (B-E) Quantitative analysis of western blot bands Figure 2. (F-J) Quantitative analysis of western blot bands Figure 3. (K-P) Quantitative analysis of western blot bands Figure 4. (Q-T) Quantitative analysis of western blot bands Figure 5. (U-V) Quantitative analysis of western blot bands Figure 6. (W-X) Quantitative analysis of western blot bands Figure 7. (Y-b) Quantitative analysis of western blot bands Figure 8. *P < 0.05, **P < 0.01. (TIF 19291 kb)
Figure S9
Quantitative analysis of ECs apoptosis induced by various treatment measured by TUNEL assay (from Figure 4-Figure 8). (A-E) Quantitative analysis of ECs apoptosis in Figure 4. (F) Quantitative analysis of ECs apoptosis in Figure 5. (G-H) Quantitative analysis of ECs apoptosis in Figure 6. (I) Quantitative analysis of ECs apoptosis in Figure 7. (J-K) Quantitative analysis of ECs apoptosis in Figure 8. *P < 0.05, **P < 0.01. (TIF 19123 kb)
Figure S10
Effects of SREBF2 on LPS-induced HUVECs injury. (A-B) SREBF2 and SCAP expression in LPS-treated (100ng/ml) HUVECs for 24 hour detected by Western blot. (C-D) Apoptosis of HUVECs (green) was measured by TUNEL assay. Nuclei were counterstained into blue. *P < 0.05, **P < 0.01. (TIF 19145 kb)
Rights and permissions
About this article
Cite this article
Dong, G., Huang, X., Wu, L. et al. SREBF2 triggers endoplasmic reticulum stress and Bax dysregulation to promote lipopolysaccharide-induced endothelial cell injury. Cell Biol Toxicol 38, 185–201 (2022). https://doi.org/10.1007/s10565-021-09593-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-021-09593-1